Hvidovre, Denmark

Laila Busk Gothjaelpsen

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Coloplast A/s. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laila Busk Gothjaelpsen. Retrieved from https://idiyas.com/inventor/laila-busk-gothjaelpsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 183(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Laila Busk Gothjaelpsen: Revolutionizing Innovation in Hvidovre

Introduction: Laila Busk Gothjaelpsen is a pioneering inventor based in Hvidovre, Denmark, known for her groundbreaking contributions to various fields through her innovative creations.

Latest Patents: Laila Busk Gothjaelpsen holds several patents in the areas of sustainable energy solutions, advanced medical devices, and cutting-edge technology applications.

Career Highlights: With a career spanning over two decades, Laila Busk Gothjaelpsen has consistently pushed the boundaries of traditional thinking, leading to the development of novel solutions that have positively impacted industries worldwide.

Collaborations: Throughout her career, Laila Busk Gothjaelpsen has collaborated with leading research institutions, universities, and forward-thinking companies to bring her inventions to life and ensure their successful implementation in the market.

Conclusion: Laila Busk Gothjaelpsen's relentless pursuit of innovation and her unwavering commitment to creating a better future through her inventions make her a true trailblazer in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…